Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Solasto Corporation (6197.T)

Compare
429.00
-13.00
(-2.94%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 6197.T
  • Previous Close 442.00
  • Open 439.00
  • Bid 427.00 x --
  • Ask 430.00 x --
  • Day's Range 423.00 - 439.00
  • 52 Week Range 418.00 - 600.00
  • Volume 510,600
  • Avg. Volume 190,527
  • Market Cap (intraday) 39.583B
  • Beta (5Y Monthly) 0.71
  • PE Ratio (TTM) 33.00
  • EPS (TTM) 13.00
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield 20.00 (4.66%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est 565.00

Solasto Corporation provides medical outsourcing services to medical institutions in Japan. The company's medical outsourcing services, including medical office work, temporary staffing, and hospital management support. It offers smart hospital, nursing care, and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.

www.solasto.co.jp

33,884

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 6197.T

View More

Performance Overview: 6197.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

6197.T
7.58%
Nikkei 225 (^N225)
15.33%

1-Year Return

6197.T
12.60%
Nikkei 225 (^N225)
15.07%

3-Year Return

6197.T
53.18%
Nikkei 225 (^N225)
21.79%

5-Year Return

6197.T
45.81%
Nikkei 225 (^N225)
89.56%

Compare To: 6197.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6197.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    39.58B

  • Enterprise Value

    47.30B

  • Trailing P/E

    33.03

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.29

  • Price/Book (mrq)

    1.80

  • Enterprise Value/Revenue

    0.35

  • Enterprise Value/EBITDA

    6.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.83%

  • Return on Assets (ttm)

    5.95%

  • Return on Equity (ttm)

    5.11%

  • Revenue (ttm)

    137.04B

  • Net Income Avi to Common (ttm)

    1.14B

  • Diluted EPS (ttm)

    13.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.29B

  • Total Debt/Equity (mrq)

    95.70%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6197.T

View More

Company Insights: 6197.T

Research Reports: 6197.T

View More

People Also Watch